Sep 29, 2022 7:00am EDT Societal CDMO Announces Signing of Multiple Agreements With New and Existing Customers
Sep 07, 2022 7:00am EDT Societal CDMO Awarded Two New CDMO Service Contracts Focused on Supporting Ongoing Clinical Development Programs for Novel Therapeutic Candidates
Aug 16, 2022 7:00am EDT Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront Land
Aug 04, 2022 7:00am EDT Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates
Aug 03, 2022 4:05pm EDT Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022
Jul 20, 2022 7:00am EDT Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
Jul 12, 2022 7:00am EDT Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products